预计医用注射器市场在 2023 年至 2031 年期间的复合年增长率为 6.6%,市场规模将从 2023 年的 XX 百万美元扩大到 2031 年的 XX 百万美元。
报告按可用性(可灭菌/可重复使用注射器、皮下注射器、口服注射器、一次性注射器、传统注射器、安全注射器、可伸缩安全注射器、非伸缩安全注射器、预充式注射器);材料(玻璃注射器、塑料注射器);类型(普通注射器、专用注射器、胰岛素注射器、结核菌素注射器、过敏注射器、其他注射器(导管注射器和血管造影注射器))进行细分。全球分析进一步细分为区域和主要国家。报告提供上述分析和细分的美元价值。
报告目的
Insight Partners 的《医用注射器市场》报告旨在描述当前形势和未来增长、主要驱动因素、挑战和机遇。这将为各种业务利益相关者提供见解,例如:
- 技术提供商/制造商:了解不断变化的市场动态并了解潜在的增长机会,从而能够做出明智的战略决策。
- 投资者:对市场增长率、市场财务预测以及整个价值链中存在的机会进行全面的趋势分析。
- 监管机构:监管市场政策和警察活动,旨在最大限度地减少滥用行为,维护投资者的信任和信心,维护市场的完整性和稳定性。
医用注射器市场细分
可用性
- 可灭菌/可重复使用注射器
- 皮下注射器
- 口服注射器
- 一次性注射器
- 传统注射器
- 安全注射器
- 可伸缩安全注射器
- 非伸缩式安全注射器
- 预充式注射器
材料
- 玻璃注射器
- 塑料注射器
类型
- 通用注射器
- 专用注射器
- 胰岛素注射器
- 结核菌素注射器
- 过敏注射器
- 其他注射器
地理
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
地理
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
医疗注射器市场增长动力
- 慢性病患病率不断上升:糖尿病、心脏病和恶性肿瘤等慢性病患病率不断上升,推动了对医用注射器的需求。这些疾病涉及注射胰岛素和生物制剂等药物。随着服药和需要注射的患者数量不断增加,医用注射器市场也一如既往地蓬勃发展,尤其注重为患有慢性病的患者创造改进和更安全的注射器类型。
- 疫苗接种计划的增长:全球范围内疫苗接种计划的增长是医疗注射器市场增长的主要因素。疫苗接种的估计覆盖率也在增加,特别是在后新冠时代,疫苗接种率的增加趋势增强,这增加了对一次性高效疫苗注射器的需求。立即接种疫苗的需求促进了低成本、即用型预充式注射器的增长,这有助于在成熟经济体和发展中经济体创造更多需求。
- 针头安全技术的进步:安全设计注射器的问世是市场增长的主要因素,安全设计注射器旨在减轻针刺伤事故中的危害。这些注射器采用可缩回的针头,采用安全系统覆盖或操作的设计,从而消除了手动操作的需要,并降低了接触血源性病毒的可能性。出于这个原因,越来越多的医疗机构关心患者和员工的安全,这使得这些注射器越来越受欢迎,从而增加了市场规模。
医疗注射器市场未来趋势
- 预充式注射器的增长:预充式注射器(尤其是用于生物制剂和疫苗的预充式注射器)的发展是医疗注射器市场增长的主要原因之一。预充式注射器更易于处理,提高剂量精度,并降低污染几率。门诊服务中提供的肠外护理服务越来越多,尤其是用于治疗慢性病和免疫程序,这产生了更多的预充式解决方案。
- 智能设备采用率提高:另一个值得关注的领域是技术推动的医疗注射器的使用。嵌入传感器或蓝牙技术的智能注射器有助于实时监控剂量、注射时间,甚至患者的依从性。因此,它们消除了患者不依从时的治疗障碍,并且由于护理人员可以使用监控功能,有助于保障安全。这一趋势归因于数字健康解决方案的兴起。
- 使用安全设计的注射器工程师:另一个非常重要的因素是使用设计好的注射器,这种注射器越来越受欢迎,目的是减少潜在的针刺伤事件。这些注射器配有可伸缩针头或自动防护罩,可以安全地避免患者和医护人员感染。所有这些都强调对针头安全的关注,以及大多数国家普遍存在的监管法规,这些注射器的供应,特别是在医院和医疗中心。
医用注射器市场机会
- 家庭医疗保健市场的扩张:家庭医疗保健的蓬勃发展为医疗注射器市场带来了盈利机会。随着越来越多的患者在家中接受各种健康问题(包括糖尿病和自身免疫性疾病)的治疗,口服注射器(最好是预先填充的,便于自行注射)变得越来越受欢迎。由于医疗保健系统希望更多地在家中治疗患者,因此更多的机构可以提供适合住院患者的注射器,供患者在家中使用。
- 生物制剂和生物仿制药需求不断增长:医疗注射器市场面临的一个主要挑战是生物药物及其生物仿制药的兴起,这些药物的给药方式非常精确。癌症、类风湿性关节炎和糖尿病等多种生物制剂的治疗都是通过注射给药的。在利润最丰厚的生物制剂市场,需要能够提供一致且无菌的选择性剂量以便于注射的注射器,从而导致注射器市场采用更先进的方法。
- 专注于可持续和环保的注射器解决方案:这主要是因为全世界比以往任何时候都更加关注设计环保的医用注射器,制造商现在也在探索使用可生物降解的材料、可回收的部件和耗能更少的制造工艺。以绿色的方式为医疗机构和患者提供更具吸引力和可访问性的选择。可以扩大业务范围,以包括向患者提供无毒注射器,而不会不尊重医疗保健行业。
医用注射器市场区域洞察
Insight Partners 的分析师已详尽解释了预测期内影响医疗注射器市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的医疗注射器市场细分和地理位置。
- 获取医用注射器市场的区域特定数据
医用注射器市场报告范围
报告属性 | 细节 |
---|---|
2023 年的市场规模 | XX 百万美元 |
2031 年市场规模 | XX 百万美元 |
全球复合年增长率(2023 - 2031) | 6.6% |
史料 | 2021-2022 |
预测期 | 2024-2031 |
涵盖的领域 | 按可用性
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
医疗注射器市场参与者密度:了解其对业务动态的影响
医疗注射器市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。
在医疗注射器市场运营的主要公司有:
- 美敦力公司
- 史密斯医疗
- 印度斯坦注射器及医疗器械有限公司
- 格雷斯海姆股份公司
- 肖特公司
免责声明:上面列出的公司没有按照任何特定顺序排列。
- 了解医用注射器市场的主要参与者概况
主要卖点
- 全面覆盖:报告全面涵盖了医疗注射器市场的产品、服务、类型和最终用户的分析,提供了整体概况。
- 专家分析:报告基于对行业专家和分析师的深入了解而编写。
- 最新信息:该报告涵盖了最新信息和数据趋势,确保了其与业务的相关性。
- 定制选项:此报告可以定制以满足特定客户要求并恰当地适应业务策略。
因此,医疗注射器市场研究报告有助于引领解读和了解行业情景和增长前景。尽管可能存在一些合理的担忧,但本报告的总体优势往往大于劣势。
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The market is expected to grow at a CAGR of 6.6%
The North America region accounts for highest revenue share medical syringe market
Medtronic plc, Smiths Medical, Hindustan Syringes & Medical Devices Limited, Gerresheimer AG, SCHOTT AG, CODAN Medizinische Geräte GmbH & Co KG, Becton, Dickinson and Company, Terumo Corporation, B. Braun Medical Inc., NIPRO Corporation are the some of the key market players operating in the medical syringe market
The final report will duly include market size and projection estimates for all the segments from 2021 to 2031, along with a revenue share and compound annual growth rate (%) for the regional
/
country-wise market wherein 2021-2022 are the historic years, 2023 is considered to be the base year, and the forecast will be provided till 2031, along with CAGR (%)
Asia Pacific is estimated to grow at the highest CAGR over the forecast year (2023 - 2031)
Rising prevalence of chronic diseases and growth of vaccination programs is the major factors boosting the medical syringe market growth
Trends and growth analysis reports related to Life Sciences : READ MORE..
1. Medtronic plc
2. Smiths Medical
3. Hindustan Syringes & Medical Devices Limited
4. Gerresheimer AG
5. SCHOTT AG
6. CODAN Medizinische Geräte GmbH & Co KG
7. Becton, Dickinson and Company
8. Terumo Corporation
9. B. Braun Medical Inc.
10. NIPRO Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.